These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17292918)

  • 1. The 2.7 A crystal structure of the autoinhibited human c-Fms kinase domain.
    Walter M; Lucet IS; Patel O; Broughton SE; Bamert R; Williams NK; Fantino E; Wilks AF; Rossjohn J
    J Mol Biol; 2007 Mar; 367(3):839-47. PubMed ID: 17292918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of the constitutive activity and STI571 resistance of Asp816Val mutant KIT receptor tyrosine kinase.
    Foster R; Griffith R; Ferrao P; Ashman L
    J Mol Graph Model; 2004 Oct; 23(2):139-52. PubMed ID: 15363456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1307-15. PubMed ID: 16226710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.
    Wodicka LM; Ciceri P; Davis MI; Hunt JP; Floyd M; Salerno S; Hua XH; Ford JM; Armstrong RC; Zarrinkar PP; Treiber DK
    Chem Biol; 2010 Nov; 17(11):1241-9. PubMed ID: 21095574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FMIP, a novel Fms-interacting protein, affects granulocyte/macrophage differentiation.
    Tamura T; Mancini A; Joos H; Koch A; Hakim C; Dumanski J; Weidner KM; Niemann H
    Oncogene; 1999 Nov; 18(47):6488-95. PubMed ID: 10597251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase.
    Mol CD; Dougan DR; Schneider TR; Skene RJ; Kraus ML; Scheibe DN; Snell GP; Zou H; Sang BC; Wilson KP
    J Biol Chem; 2004 Jul; 279(30):31655-63. PubMed ID: 15123710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation.
    Cowan-Jacob SW; Fendrich G; Manley PW; Jahnke W; Fabbro D; Liebetanz J; Meyer T
    Structure; 2005 Jun; 13(6):861-71. PubMed ID: 15939018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function studies on human macrophage colony-stimulating factor (M-CSF).
    Koths K
    Mol Reprod Dev; 1997 Jan; 46(1):31-7; discussion 37-8. PubMed ID: 8981361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a new potent bisamide FMS kinase inhibitor.
    El-Gamal MI; Jung MH; Oh CH
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3216-8. PubMed ID: 20457522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).
    Ali S; Ali S
    Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots.
    Savvides SN; Boone T; Andrew Karplus P
    Nat Struct Biol; 2000 Jun; 7(6):486-91. PubMed ID: 10881197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed conformational dynamics of juxtamembrane region and activation loop in c-Kit kinase activation process.
    Zou J; Wang YD; Ma FX; Xiang ML; Shi B; Wei YQ; Yang SY
    Proteins; 2008 Jul; 72(1):323-32. PubMed ID: 18214972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of c-Met kinase domain complexes: a new specific catalytic site receptor model for defining binding modes of ATP-competitive ligands.
    Asses Y; Leroux V; Tairi-Kellou S; Dono R; Maina F; Maigret B
    Chem Biol Drug Des; 2009 Dec; 74(6):560-70. PubMed ID: 19909299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The M-CSF receptor substrate and interacting protein FMIP is governed in its subcellular localization by protein kinase C-mediated phosphorylation, and thereby potentiates M-CSF-mediated differentiation.
    Mancini A; Koch A; Whetton AD; Tamura T
    Oncogene; 2004 Aug; 23(39):6581-9. PubMed ID: 15221008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the tyrosine kinase domain of colony-stimulating factor-1 receptor (cFMS) in complex with two inhibitors.
    Schubert C; Schalk-Hihi C; Struble GT; Ma HC; Petrounia IP; Brandt B; Deckman IC; Patch RJ; Player MR; Spurlino JC; Springer BA
    J Biol Chem; 2007 Feb; 282(6):4094-101. PubMed ID: 17132624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
    Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
    Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of human Fyn kinase domain complexed with staurosporine.
    Kinoshita T; Matsubara M; Ishiguro H; Okita K; Tada T
    Biochem Biophys Res Commun; 2006 Aug; 346(3):840-4. PubMed ID: 16782058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
    Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
    Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic structure of the SH3 domain of the human c-Yes tyrosine kinase: loop flexibility and amyloid aggregation.
    Martín-García JM; Luque I; Mateo PL; Ruiz-Sanz J; Cámara-Artigas A
    FEBS Lett; 2007 May; 581(9):1701-6. PubMed ID: 17418139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for compound C inhibition of the human AMP-activated protein kinase α2 subunit kinase domain.
    Handa N; Takagi T; Saijo S; Kishishita S; Takaya D; Toyama M; Terada T; Shirouzu M; Suzuki A; Lee S; Yamauchi T; Okada-Iwabu M; Iwabu M; Kadowaki T; Minokoshi Y; Yokoyama S
    Acta Crystallogr D Biol Crystallogr; 2011 May; 67(Pt 5):480-7. PubMed ID: 21543851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.